Gallinée expands tenfold, fast-tracks European development

On the time of its acquisition by the Shiseido Group in 2022, Gallinée generated 95% of its gross sales by means of on-line channels. Since then, the model has considerably expanded its footprint throughout Europe and now counts 1,250 energetic factors of sale. This profitable integration is predicated on combining Gallinée’s consumer-centric, microbiome-driven strategy with Shiseido’s analysis capabilities.

Pilot model

At this time, Gallinée performs a key position within the improvement of Shiseido’s pharmacy channel throughout Europe. The French microbiome specialist acts as a pilot model inside the European dermocosmetics market, enabling the group to construct and deploy a technique tailor-made to the pharmacy market, recognized as a precedence development driver.

“Gallinée completely illustrates our ambition to develop science-driven skincare manufacturers inside the pharmacy channel, the place experience, belief {and professional} suggestion are important,” explains Florian d’Hauteville, Chief Enterprise Officer, Shiseido EMEA. “Its progressive enlargement on this distribution channel is a part of a long-term development technique constructed on science, operational excellence and sustainable worth creation.”

The model now plans to speed up its improvement with the opening of a minimum of 300 pharmacies per nationwide market, with a longer-term ambition of increasing to five,000 pharmacies throughout France, Italy, and Spain.

Microbiome-focused innovation

The transfer into the pharmacy channel — an atmosphere grounded in belief and knowledgeable suggestion — was a pure match for a model devoted to addressing pores and skin well being considerations.

On the coronary heart of Gallinée’s technique lies a easy philosophy: help the pores and skin’s ecosystem with out disrupting it.

“This strategy is absolutely aligned with Shiseido’s scientific technique, which has established the microbiome as a key pillar of its analysis and innovation,” says Marie Drago, Founder and Chief Inventive Officer of Gallinée. The Group attracts on devoted analysis facilities, bringing collectively experience in formulation, toxicology, security evaluation and high quality management, to develop a deeper understanding of the interactions between the pores and skin and its microbiome.

At this time, Gallinée advantages from structured microbiome experience and an innovation pipeline protected by mental property. The model holds 4 patents underpinning a particular “microbiome system.” Amongst these patents is the usage of vinegar as a postbiotic ingredient, a primary in skincare.

“Becoming a member of the Shiseido Group has enabled us to speed up our development with out ever compromising our DNA. Increasing into pharmacy was a pure step: it’s a channel the place we will converse significantly about pores and skin steadiness and long-term care. Rising our presence whereas remaining clear and actually helpful to shoppers is strictly what we’re constructing right now,” provides Marie Drago.

First-to-market merchandise

This structured enlargement is supported by the robust efficiency of Gallinée’s iconic merchandise, beginning with the Face Vinegar, now offered each half-hour worldwide, almost ten years after its launch. In 2025, gross sales of the Vinegar vary doubled in comparison with 2024, confirming its standing as a flagship franchise for the model. The Vinegar vary accounts for 23% of whole model gross sales in 2025, whereas the Common vary stays the model’s main pillar, representing 28% of whole gross sales.

On the similar time, Gallinée continues to drive sustained innovation. The Youthful Eye Cream entered the model’s prime 5 references after simply 4 months available on the market in 2025. Since becoming a member of Shiseido, Gallinée has launched 5 new facial merchandise, all made in France.